• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Hyperspectral Tissue Oygenation Mapping: A Vital Tool

  • Mon, 11/9/09 - 5:07pm
  • 0 Comments
  • 2400 reads
Start Page: 
161
End Page: 
161
Author(s): 

Marc E. Mitchell, MD

Address for correspondence: Marc E. Mitchell, M.D. James D. Hardy Professor and Chair, Department of Surgery, University of Mississippi, 2500 North State Street Jackson, MS 39216. Email: memitchell@surgery.umsmed.edu


In the current issue of Vascular Disease Management, Neville and Gupta1 use hyperspectral tissue oxygenation mapping (HTOM) technology to determine tissue oxygen delivery, oxygen extraction and oxygen saturation in the lower and upper extremities of normal individuals without vascular disease. HTOM quantifies oxyhemoglobin, deoxyhemoglobin and oxygen saturation in the dermis by measuring light absorption at specific wavelengths between 450 and 650 nm. The authors demonstrated that HTOM measurements are reproducible, and that oxyhemoglobin, deoxyhemoglobin and oxygen saturation measurement correlate in near real time with cuff induced ischemia. This technology has the ability to precisely map tissue oxygen delivery, extraction and saturation in specific areas, and demonstrated that the plantar surface of the foot and the palmar surface of the hand have the highest levels of oxyhemoglobin and oxygen saturation in the extremities.

Previous work has shown possible clinical efficacy for HTOM in determining the ability of wounds to heal, and in the management of extremity wounds such as ulcers in patients with critical limb ischemia. The current study compliments this earlier work, by determining normative ranges for tissue oxygen delivery, extraction and saturation in individuals with no evidence of arterial or venous disease. This baseline information is essential if HTOM is to be used clinically.

HTOM has the potential for assisting vascular surgeons in deciding which wounds are likely to heal in patients with arterial and venous disease. Over the years many techniques, such as ankle brachial index, toe pressure measurement, transcutaneous tissues oxygen saturation and skin temperature measurement, have been used to predict wound healing. None has demonstrated significant benefit over the sound clinical judgment of an experienced vascular surgeon. HTOM has the unique ability to map oxygen delivery, extraction and saturation to a precise area of the extremity, such as the region of a wound. This may be a significant advantage over these other techniques, and may prove useful to vascular surgeons faced with difficult clinical decisions. Additionally, HTOM may be useful as a tool to determine the effectiveness of endovascular and open surgical revascularization, as well as a method to follow the patency of those procedures. HTOM may indeed become a technology with clinical importance to vascular surgeons in the future.

Reference

1. Neville R. Gupta S. Establishment of normative perfusion values using hyperspectral tissue oxygenation mapping technology. Vasc Disease Mgmt 2009;6:156–161.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
    Fri, 02/10/12 - 11:12am
  • Stereotaxis Announces European Adoption Milestone and Health Canada Market Clearance for Vdrive System
    Fri, 02/10/12 - 11:08am
  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications